Ticker Details
Revolution Medicines, Inc.
IPO Date:	February 13, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$19.07B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.87 | 2.60%
Avg Daily Range (30 D):	$1.37 | 1.42%
Avg Daily Range (90 D):	$1.63 | 1.76%

Institutional Daily Volume
Avg Daily Volume:	.97M
Avg Daily Volume (30 D):	1.43M
Avg Daily Volume (90 D):	2.27M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	63

Institutional Trades
Total Institutional Trades:	5,812
Avg Institutional Trade:	$3.85M
Avg Institutional Trade (30 D):	$10.87M
Avg Institutional Trade (90 D):	$8.11M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$8.37M
Avg Closing Trade (30 D):	$45.4M
Avg Closing Trade (90 D):	$40.23M
Avg Closing Volume:	198.12K

News

Mar 25, 2026 @ 3:20 PM Merck's $6.7 Billion Terns Pharmaceuticals Acquisi... Source: Vandana Singh

Mar 19, 2026 @ 7:03 PM Is Relay Therapeutics a Buy in 2026? One Instituti... Source: Andy Gould

Feb 25, 2026 @ 8:28 PM Protagonist Stock Up 120%, but One Fund Just Revea... Source: Jonathan Ponciano

Feb 25, 2026 @ 8:19 PM Disc Medicine Stock Is Swinging, but This Fund's N... Source: Jonathan Ponciano

Jan 29, 2026 @ 1:00 PM Breakthru Medicine emerges from stealth with $60M ... Source: Not Specified

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-5.95	$-1.89	$-5.95
Diluted EPS	$-5.95	$-1.89	$-5.95
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-1131.3M	$-364.89M	$-1131.3M
Operating Income / Loss	$-1182.37M	$-361.63M	$-1182.37M
Cost of Revenue
Net Cash Flow	$-158.16M	$166.3M	$-158.16M
PE Ratio